HSP90AA1 and breast carcinoma: To explore the performance of plasma Hsp90α in breast cancer auxiliary diagnosis, 111 participants, including 44 breast cancer patients, 25 patients with at-risk breast diseases and 42 healthy individuals, were enrolled from hospitals into the test cohort (Figure 1A and Supplementary Table S1).